COSMO Pharmaceuticals Aktie
| 99,50EUR | 0,50EUR | 0,51% |
WKN DE: A2AJ68 / ISIN: NL0011832936
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 290 | 295 | 325 | 321 | 324 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,24 | 0,35 | 0,28 | 0,79 | 0,30 |
Bilanz (in Mio. CHF) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 286 | 302 | 95 | 190 | 171 |
| Summe Anlagevermögen | 549 | 448 | 420 | 417 | 399 |
| Summe Aktiva | 835 | 750 | 515 | 607 | 570 |
Bilanz (in Mio. CHF) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 311 | 299 | 116 | 133 | 115 |
| Summe Eigenkapital | 524 | 451 | 399 | 474 | 455 |
| Summe Passiva | 835 | 750 | 515 | 607 | 570 |
Adresse
| Riverside II, 2 Dublin | |
| Telefon | +353 (1) 8170370 |
| Fax | +353 (1) 8230718 |
| Internet | http://www.cosmopharma.com |
Management
|
Alessandro Della Chà
Chairman |
|
Andrea Cherubini
Chief AI Officer |
|
Davide Malavasi
Director-Qualified Person & Technical |
|
Diana Harbort
President-Dermatology |
|
Dominika Spilarova
Chief of Staff & Chief Strategy Officer |
|
Egle Gedrimaite
Head-Global Business Development |
|
Federico Sommariva
Chief Legal Counsel |
|
Giovanni di Napoli
Chief Executive Officer & Executive Director |
|
Giulio Evangelisti
Senior VP-Manufacturing, Service & Security |
|
Hazel Winchester
Head-Investor Relations |
|
John O'Dea
Non-Executive Director |
|
Luigi Longo
Chief Scientific Office |
|
Marco Lecchi
Chief Operating Officer |
|
Maria Grazia Roncarolo
Independent Non-Executive Director |
|
Mauro Severino Ajani
Non-Executive Director |
|
Nhan Ngo Dinh
President-Cosmo Intelligent Medical Devices |
|
Niall Donnelly
Executive Director & Chief Sustainability Officer |
|
Paolo Lanzarotti
Manager-R&D Analytical Development |
|
Roberto Villa
Chief Manufacturing Officer |
|
Silvana Perretta
Non-Executive Director |
|
Svetlana Sigalova
Chief Financial Officer |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.